natgillin/translations-raw huggingface dataset:
In particular, the Authority considers that attracting an investment to a poorer region (as defined by the higher regional aid ceiling) is more beneficial for cohesion within the EEA than if the same investment is located in a more advantaged region.
Nadzorni organ meni, da je privabljanje naložb v revnejšo regijo (kot je določeno z višjimi zgornjimi mejami regionalne pomoči) koristnejše za kohezijo v EGP kot izvajanje istih naložb v regijah z več prednostmi.
Thus, under scenario 2, where evidence has to be given of an alternative location, an assessment that without aid the investment would have been located to a poorer region (more regional handicaps — higher maximum regional aid intensity) or to a region that is considered to have the same regional handicaps as the target region (same maximum regional aid intensity) will constitute a negative element in the overall balancing test that is unlikely to be compensated by any positive elements because it runs counter to the very rationale of regional aid.
Tako bo ocena v okviru možnosti 2, pri kateri je potreben dokaz o drugi lokaciji, da bi se naložbe brez pomoči izvajale v revnejši regiji (več regionalnih problemov – višja stopnja najvišje intenzivnosti regionalne pomoči) ali v regiji, za katero se šteje, da ima iste regionalne probleme kot ciljna regija (enaka najvišja intenzivnost regionalne pomoči), v splošnem testu tehtanja predstavljala negativni element, pri čemer je malo verjetno, da bi ga izravnali kakršni koli pozitivni elementi, ker je to v nasprotju z osnovnim načelom regionalne pomoči.
On the other hand, the positive effects of regional aid which merely compensate for the difference in net costs relative to a more developed alternative investment location (and thus fulfils the proportionality test above, in addition to the ‘positive effect’ requirements as to objective, appropriateness and incentive effect), will normally be considered, under the balancing test, to outweigh any negative effects in the alternative location for new investment.
Kar zadeva pozitivne učinke regionalne pomoči, ki samo izravnajo razliko neto stroškov v primerjavi z bolj razvito alternativno naložbeno lokacijo (in tako izpolni zgornje merilo sorazmernosti, pa tudi zahtevo po „pozitivnem učinku“ glede ciljev, primernosti in spodbujevalnega učinka), pa se po drugi strani praviloma šteje, da pri testu tehtanja prevladajo nad negativnimi učinki na alternativni lokaciji nove naložbe.
However, where there is credible evidence that the State aid would result in a substantial loss of jobs in existing locations within the territory covered by the EEA Agreement, which would otherwise have been likely to be preserved in the medium term, the social and economic effects on that existing location will have to be taken into account in the balancing exercise.
Če pa obstajajo prepričljivi dokazi, da bi državna pomoč povzročila izgubo znatnega števila delovnih mest na že obstoječih lokacijah na ozemlju, ki ga zajema Sporazum EGP, ki bi bila drugače srednjeročno verjetno ohranjena, je treba pri tehtanju upoštevati socialne in gospodarske učinke na te obstoječe lokacije.
The Authority may, following the formal investigation procedure laid down in Article 6 of Part II of Protocol 3 to the Surveillance and Court Agreement, close the procedure with a decision pursuant to Article 7 of that Protocol.
Nadzorni organ lahko ob upoštevanju formalnega postopka preiskave, določenega v členu 6 dela II Protokola 3 k Sporazumu o nadzornem organu in sodišču, konča postopek z odločbo v skladu s členom 7 Protokola.
The Authority may decide either to approve, condition or prohibit the aid [22].
Nadzorni organ se lahko odloči, da bo pomoč odobril, pogojno odobril ali prepovedal [22].
If it adopts a conditional decision pursuant to Article 7(4) of that Protocol, it may attach conditions to limit the potential distortion of competition and ensure proportionality.
Če sprejme pogojno odločbo v skladu s členom 7(4) Protokola, lahko doda pogoje, da omeji možno izkrivljanje konkurence in zagotovi sorazmernost.
In particular, it may reduce the notified amount of aid or aid intensity to a level considered to be proportional and thus compatible with the common market.
Zlasti lahko zmanjša priglašeni znesek pomoči ali intenzivnost pomoči do stopnje, ki se šteje za sorazmerno in zato združljivo s skupnim trgom.
This chapter corresponds to Communication from the European Commission concerning the criteria for an in-depth assessment of regional aid to large investment projects, OJ C 223, 16.9.2009, p. 3.
To poglavje se ujema s sporočilom Evropske komisije o merilih za podrobno oceno regionalne pomoči za velike naložbene projekte, UL C 223, 16.9.2009, str. 3.
The Chapter on national regional aid for 2007-13 corresponds to Communication from the Commission — Guidelines on national regional aid for 2007-13, OJ C 54, 4.3.2006, p. 13.
Poglavje o državni regionalni pomoči za 2007–2013 se ujema s sporočilom Komisije – Smernice o državni regionalni pomoči za 2007–2013, UL C 54, 4.3.2006, str. 13.
As defined in paragraph 49 and footnotes 46 and 47 of the Regional Aid Guidelines.
Kot je opredeljen v odstavku 49 ter opombah 46 in 47 Smernic o regionalni pomoči.
Cf. Section 4.3 of the Regional Aid Guidelines.
Glej razdelek 4.3 Smernic o državni regionalni pomoči.
Cf. paragraph 56 of the Regional Aid Guidelines.
Glej odstavek 56 Smernic o državni regionalni pomoči.
Cf. paragraph 53 of the Regional Aid Guidelines.
Glej razdelek 53 Smernic o državni regionalni pomoči.
Cf. point 26A.3(4) of Chapter 26A of the Authority’s Multisectoral framework on regional aid for large investment projects which corresponded to the European Commission’s Multisectoral framework on regional aid for large investment projects (OJ C 70, 19.3.2002, p. 8, as amended in OJ C 263, 1.11.2003, p. 3).
Glej točko 26A.3(4) Večsektorskega okvira o regionalni pomoči za velike investicijske projekte, ki se ujema z Večsektorskim okvirom o regionalni pomoči za velike investicijske projekte Evropske komisije (UL C 70, 19.3.2002, str. 8, kakor je bil spremenjen v UL C 263, 1.11.2003, str. 3).
Cf. paragraph 57 of the Regional Aid Guidelines.
Glej odstavek 57 Smernic o državni regionalni pomoči.
Cf. paragraphs 11 and 20 of the State Aid Action Plan (COM(2005) 107 final).
Glej odstavka 11 in 20 akcijskega načrta državnih pomoči (COM(2005) 107 konč.).
Cf. paragraph 30 of the Regional Aid Guidelines.
Glej odstavek 30 Smernic o državni regionalni pomoči.
Such investments may create conditions allowing further investments that are able to survive without additional aid.
Takšne naložbe lahko ustvarijo razmere, v katerih so možne nadaljnje naložbe, ki lahko preživijo brez dodatne pomoči.
Where doubts remain as to the appropriate definition of the relevant markets, the Authority will identify these in the decision to initiate the formal investigation procedure pursuant to Article 1(2) of Part I of Protocol 3.
Če še vedno obstajajo pomisleki v zvezi z ustrezno opredelitvijo upoštevnega trga, jih bo Nadzorni organ navedel v sklepu za začetek formalnega postopka preiskave v skladu s členom 1(2) dela I Protokola 3.
Market power is the power to influence market prices, output, the variety or quality of goods and services, or other parameters of competition on the market for a significant period of time.
Tržna moč je moč, ki daljše časovno obdobje vpliva na tržne cene, donos, raznolikost ter kakovost blaga in storitev ali druge parametre konkurence na trgu.
For this purpose, the Authority may consider the Herfindahl-Hirschman index (HHI).
V ta namen lahko Nadzorni organ upošteva Herfindahl-Hirschmanov indeks.
This index provides a basic analysis of the market structure.
Ta indeks omogoča osnovno analizo tržne strukture.
In a market with few market players where several of them have a relatively high market share, a high market share of the beneficiary might be less of a concern for competition.
Na trgu z majhnim številom udeležencev, pri čemer ima nekaj od njih sorazmerno velik tržni delež, bi velik tržni delež upravičenca do pomoči manj ogrožal konkurenco.
These entry barriers include legal barriers (in particular intellectual property rights), economies of scale and scope, access barriers to networks and infrastructure.
Te ovire za vstop na trg vključujejo pravne ovire (zlasti pravice intelektualne lastnine), ekonomijo obsega in dosega, ovire pri dostopu do omrežij in infrastrukture.
Where the aid concerns a market where the aid beneficiary is an incumbent, possible barriers to entry may exacerbate the potential market power wielded by the aid beneficiary and thus the possible negative effects of that market power.
Kadar pomoč zadeva trg, na katerem je upravičenec do pomoči uveljavljen, je lahko možna tržna moč, ki jo ima upravičenec do pomoči, zaradi morebitnih ovir za vstop slabša, pri čemer se okrepijo tudi negativni učinki navedene tržne moči.
Where there are strong buyers in the market, it is less likely that an aid beneficiary can increase prices vis-à-vis these strong buyers.
Če so na trgu prisotni močni kupci, je zvišanje cen upravičenca do pomoči manj verjetno.
In this context, a market is meant to be ‘underperforming’ if its average annual growth rate in the reference period does not exceed the growth rate of EEA’s GDP.
V tem smislu se šteje, da je trg „slabo delujoč“, če njegova povprečna letna stopnja rasti v referenčnem obdobju ne preseže stopnje rasti BDP v EGP.
In particular, additional activity or increased standard of living in the assisted area may increase demand for products and services originating from other parts of the EEA.
Dodatna poslovna dejavnost oziroma višji življenjski standard na območju, ki prejema pomoč, lahko povečata povpraševanje po proizvodih in storitvah iz drugih delov EGP.
Especially if they operate in local markets in the region.
Zlasti, če so dejavni na lokalnih trgih v regiji.
When the aid is granted on the basis of an existing regional aid scheme, it is however to be noted that the EFTA State retains the possibility to grant such aid up to the level which corresponds to the maximum allowable amount that an investment with eligible expenditure of EUR 100 million can receive under the applicable rules.
Vendar je treba upoštevati, da če je pomoč dodeljena na podlagi obstoječe sheme regionalne pomoči, država Efte ohrani možnost dodelitve take pomoči do stopnje, ki ustreza najvišjemu dovoljenemu znesku, ki ga lahko v skladu z veljavnimi pravili prejme naložba z upravičenimi odhodki v višini 100 milijonov EUR.
Paragraph 2 of the Regional Aid Guidelines sets out that: ‘By addressing the handicaps of the disadvantaged regions, national regional aid promotes the economic, social and territorial cohesion of EFTA States and the EEA as a whole’.
Odstavek 2 Smernic o državni regionalni pomoči določa, da „Z obravnavanjem razvojnih problemov v prikrajšanih regijah nacionalna regionalna pomoč spodbuja gospodarsko, socialno in ozemeljsko kohezijo držav Efte ter EGP kot celote“.
Paragraph 3 of the Regional Aid Guidelines adds that: ‘National regional investment aid is designed to assist the development of the most disadvantaged regions by supporting investment and job creation. It promotes the expansion and diversification of the economic activities of enterprises located in the less-favoured regions, in particular by encouraging firms to set up new establishments there’.
Odstavek 3 Smernic o državni regionalni pomoči določa: „Državna regionalna pomoč za naložbe je namenjena pomoči pri razvoju najbolj prikrajšanih regij s podpiranjem naložb in ustvarjanja delovnih mest. Pospešuje širitev in diverzifikacijo gospodarskih dejavnosti podjetij iz manj razvitih regij, zlasti s spodbujanjem podjetij k ustanavljanju novih ustanov v teh regijah.“
It will need to provide clear evidence that the aid effectively has an impact on the investment choice or the location choice.
Predložiti bo morala jasne dokaze, da pomoč učinkovito vpliva na izbiro v zvezi z naložbo ali lokacijo.
It will have to specify which scenario applies.
Morala bo navesti, katera možnost se uporablja.
No 159/10/COL
št. 159/10/COL
concerning additional guarantees for Norway relating to infectious bovine rhinotracheitis
o dodatnih jamstvih za Norveško glede infekcioznega bovinega rinotraheitisa
Having regard to the Agreement on the European Economic Area, in particular Article 17 and Protocol 1 to the Agreement, in particular Article (4)(d) thereof,
ob upoštevanju Sporazuma o Evropskem gospodarskem prostoru, zlasti člena 17 Sporazuma in Protokola 1 k Sporazumu ter zlasti člena (4)(d) Protokola,
Having regard to the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice, in particular Article 5(2)(d) and Protocol 1 to the Agreement, in particular Article 1(c) thereof,
ob upoštevanju Sporazuma med državami Efte o ustanovitvi Nadzornega organa in Sodišča, zlasti člena 5(2)(d) Sporazuma in Protokola 1 k Sporazumu ter zlasti člena 1(c) Protokola,
Having regard to the Act referred to at point 4.1.1 of Chapter I of Annex I to the EEA Agreement, Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine [1], as amended, and adapted to the EEA Agreement by Protocol 1 thereto, in particular Article 10(1) thereof,
ob upoštevanju akta iz točke 4.1.1 poglavja I Priloge I k Sporazumu EGP: Direktiva Sveta 64/432/EGS z dne 26. junija 1964 o problemih v zvezi z zdravstvenim varstvom živali, ki vplivajo na trgovino z govedom in prašiči znotraj Skupnosti [1], kakor je bila spremenjena in prilagojena Sporazumu EGP s Protokolom 1 k Sporazumu, in zlasti členu 10(1) Sporazuma,
Having regard to the Act referred to at point 4.2.80 of Chapter I of Annex I to the EEA Agreement, Commission Decision 2004/558/EC of 15 July 2004 implementing Council Directive 64/432/EEC as regards additional guarantees for intra-Community trade in bovine animals relating to infectious bovine rhinotracheitis and the approval of the eradication programmes presented by certain Member States [2], as amended,
ob upoštevanju akta iz točke 4.2.80 poglavja I Priloge I k Sporazumu EGP: Odločba Komisije 2004/558/ES z dne 15. julija 2004 o izvajanju Direktive Sveta 64/432/EGS v zvezi z dodatnimi jamstvi za trgovino z govedom med državami članicami Skupnosti v povezavi z infekcioznim bovinim rinotraheitisom in v zvezi s potrditvijo programov za izkoreninjenje, predloženih s strani nekaterih držav članic [2], kakor je bila spremenjena,
Having regard to the EFTA Surveillance Authority Decision No 74/94/COL of 27 June 1994 concerning additional guarantees relating to infectious bovine rhinotracheitis for bovines destined for Norway [3] amending the EFTA Surveillance Authority Decision No 31/94/COL [4], granting Norway certain additional guarantees to protect its disease free status of infectious bovine rhinotracheitis (IBR),
ob upoštevanju Odločbe Nadzornega organa Efte št. 74/94/COL [3] z dne 27. junija 1994 o spremembi Odločbe št. 31/94/COL [4], ki Norveški dodeljuje določena dodatna jamstva, da zaščiti svoj status odsotnosti bolezni infekcioznega bovinega rinotraheitisa (IBR),
By Decision No 74/94/COL, Norway was granted additional guarantees relating to infectious bovine rhinotracheitis for bovines.
Z Odločbo št. 74/94/COL so bila Norveški dodeljena dodatna jamstva glede infekcioznega bovinega rinotraheitisa pri govedu.
Since the adoption of Decision No 74/94/COL, the European Union’s legislation on additional guarantees for infectious bovine rhinotracheitis has been amended to ensure consistency with the international rules on this disease and better control within the Union.
Od sprejetja Odločbe Nadzornega organa št. 74/94/COL je bila zakonodaja Evropske unije o dodatnih jamstvih glede infekcioznega bovinega rinotraheitisa spremenjena, da bi se zagotovila skladnost z mednarodnimi pravili glede te bolezni in boljši nadzor nad to boleznijo v Uniji.
By Decision of the EEA Joint Committee No 48/2005 [5], Decision 2004/558/EC, as amended, was incorporated into the EEA Agreement as point 4.2.80 of Chapter I of Annex I to that Agreement.
S Sklepom Skupnega odbora EGP št. 48/2005 [5] se je Odločba 2004/558/ES, kakor je bila spremenjena, vključila v Sporazum EGP pod točko 4.2.80 poglavja I Priloge I k Sporazumu.
The Norwegian Government considers that its territory is free from infectious bovine rhinotracheitis’ disease in accordance with Article 10(1) of Directive 64/432/EEC.
Norveška vlada meni, da na njenem ozemlju ni bolezni infekcioznega bovinega rinotraheitisa v skladu s členom 10(1) Direktive 64/432/EGS.
Norway has submitted supporting documentation to the EFTA Surveillance Authority substantiating that monitoring of the situation is continued and, hence, that adequate surveillance is in place to make sure that the Norwegian territory is free from infectious bovine rhinotracheitis.
Norveška je Nadzornemu organu Efte predložila dokazno dokumentacijo o nadaljnjem spremljanju stanja in izvajanju ustreznega nadzora za zagotovitev, da na ozemlju Norveške ni bolezni infekcioznega bovinega rinotraheitisa.
Norway has requested the EFTA Surveillance Authority to update Decision No 74/94/COL in order to take account of the new legislative changes in the field of additional guarantees for intra-Union trade in bovines relating to infectious bovine rhinotracheitis’ disease.
Norveška je od Nadzornega organa Efte zahtevala, da posodobi svojo Odločbo št. 74/94/COL, da se bodo upoštevale nove zakonodajne spremembe na področju dodatnih jamstev glede bolezni infekcioznega bovinega rinotraheitisa za trgovino z govedom znotraj Unije.
It is therefore appropriate, for the sake of clarity and legal consistency, to repeal Decision No 74/94/COL in accordance with the latest legislative changes in the field of additional guarantees for intra-Union trade in bovines relating to infectious bovine rhinotracheitis’ disease.
Zato bi bilo za večjo jasnost in pravno doslednost Odločbo št. 74/94/COL ustrezno razveljaviti v skladu z zadnjimi zakonodajnimi spremembami na področju dodatnih jamstev glede bolezni infekcioznega bovinega rinotraheitisa za trgovino z govedom znotraj Unije.
The new Decision will maintain the same guarantees previously granted to Norway as well as it will align them with the new criteria set out in relevant EEA legislation, in particular Decision 2004/558/EC, as amended.
V novi odločbi bodo jamstva, ki so bila predhodno dodeljena Norveški, ostala, poleg tega se bodo uskladila z novimi merili, določenimi z zadevno zakonodajo EGP, zlasti Odločbo 2004/558/ES, kakor je bila spremenjena.
All regions in Norway are free of the infectious bovine rhinotracheitis’ disease.
V nobeni regiji Norveške ni bolezni infekcioznega bovinega rinotraheitisa.
Norway is granted the additional guarantees relating to infectious bovine rhinotracheitis’ disease laid down in Decision 2004/558/EC, as amended, when trading bovines within the European Economic Area.
Norveški se dodelijo dodatna jamstva glede bolezni infekcioznega bovinega rinotraheitisa iz Odločbe 2004/558/ES, kakor je bila spremenjena, za trgovino z govedom v Evropskem gospodarskem prostoru.
Norway has the same status as those EU Member States listed in Annex II to Decision 2004/558/EC, as amended.
Norveška ima enak status kot države članice EU, ki so navedene v Prilogi II k Odločbi 2004/558/ES, kakor je bila spremenjena.
Decision No 74/94/COL is hereby repealed.
Odločba št. 74/94/COL se razveljavi.
This Decision shall enter into force on 21 April 2010.
Ta odločba začne veljati 21. aprila 2010.
OJ L 249, 23.7.2004, p. 20 and EEA Supplement No 22, 24.4.2008, p. 170.
UL L 249, 23.7.2004, str. 20 in Dopolnilo EGP št. 22, 24.4.2008, str. 170.
OJ L 247, 22.9.1994, p. 50.
UL L 247, 22.9.1994, str. 50.
OJ L 138, 2.6.1994, p. 43.
UL L 138, 2.6.1994, str. 43.
OJ L 239, 15.9.2005, p. 15.
UL L 239, 15.9.2005, str. 15.
No 160/10/COL
št. 160/10/COL
concerning additional guarantees for Norway relating to Aujeszky’s disease
o dodatnih jamstvih za Norveško glede bolezni Aujeszkega
Having regard to the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice, in particular Article 5 (2)(d) and Protocol 1 to the Agreement, in particular Article 1(c) thereof,
ob upoštevanju Sporazuma med državami Efte o ustanovitvi Nadzornega organa in Sodišča, zlasti člena 5(2)(d) Sporazuma in Protokola 1 k Sporazumu ter zlasti člena 1(c) Protokola,
Having regard to the Act referred to in point 4.1.1 of Chapter I in Annex I to the Agreement on European Economic Area concerning animal health problems affecting intra-Community trade in bovine animals and swine, Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine [1], as amended, and adapted to the EEA Agreement by Protocol 1 thereto, in particular Articles 8 and 10(1) thereof,
ob upoštevanju akta iz točke 4.1.1 poglavja I Priloge I k Sporazumu o Evropskem gospodarskem prostoru o problemih zdravstvenega varstva živali, ki vplivajo na trgovino z govedom in prašiči znotraj Skupnosti: Direktiva Sveta 64/432/EGS z dne 26. junija 1964 o problemih v zvezi z zdravstvenim varstvom živali, ki vplivajo na trgovino z govedom in prašiči znotraj Skupnosti [1], kakor je bila spremenjena in prilagojena Sporazumu EGP s Protokolom 1 k Sporazumu, in zlasti členu 8 ter členu 10(1) Sporazuma,
Having regard to the Act referred to at point 4.2.84 of Chapter I of Annex I to the EEA Agreement, Commission Decision 2008/185/EC of 21 February 2008 in intra-Community trade of pigs relating to Aujeszky’s disease and criteria to provide information on this disease [2], as amended,
ob upoštevanju akta iz točke 4.2.84 poglavja I Priloge I k Sporazumu EGP: Odločba Komisije 2008/185/ES z dne 21. februarja 2008 o dodatnih jamstvih za trgovino s prašiči v Skupnosti glede bolezni Aujeszkega in o merilih zazagotavljanje podatkov o tej bolezni [2], kakor je bila spremenjena,
Having regard to the EFTA Surveillance Authority Decision No 226/96/COL of 4 December 1996 replacing Decision No 31/94/COL concerning additional guarantees relating to Aujeszky’s disease for pigs destined to EFTA States or regions free of the disease, as amended by Decision No 75/94/COL, in so far as these Decisions concern Norway [3],
ob upoštevanju Odločbe Nadzornega organa Efte št. 226/96/COL [3] z dne 4. decembra 1996, ki je nadomestila Odločbo št. 31/94/COL o dodatnih jamstvih glede bolezni Aujeszkega za prašiče, ki so namenjeni v države Efte ali regije, v katerih te bolezni ni,
By Decision No 226/96/COL Norway was granted additional guarantees relating to Aujeszky’s disease.
Z Odločbo št. 226/96/COL so bila Norveški dodeljena dodatna jamstva glede bolezni Aujeszkega.
Since the adoption of Decision No 226/96/COL the European Union’s legislation on additional guarantees for Aujeszky’s disease has been amended to ensure consistency with the international rules on this disease and better control over it within the Union.
Od sprejetja Odločbe št. 226/96/COL je bila zakonodaja Evropske unije o dodatnih jamstvih glede bolezni Aujeszkega spremenjena, da bi se zagotovila skladnost z mednarodnimi pravili glede te bolezni in boljši nadzor nad to boleznijo v Uniji.
By Decision of the EEA Joint Committee No 55/2009 [4], Decision 2008/185/EC, as amended, was incorporated into the EEA Agreement as point 4.2.84 of Chapter I of Annex I to that Agreement.
S Sklepom Skupnega odbora EGP št. 55/2009 [4] se je Odločba 2008/185/ES, kakor je bila spremenjena, vključila v Sporazum EGP pod točko 4.2.84 poglavja I Priloge I k Sporazumu.
The Norwegian Government considers that its territory is free from Aujeszky’s disease in accordance with Article 10(1) of Directive 64/432/EEC.
Norveška vlada meni, da na njenem ozemlju ni bolezni Aujeszkega v skladu s členom 10(1) Direktive 64/432/EGS.
Norway has submitted supporting documentation to the EFTA Surveillance Authority, in particular, substantiating that monitoring of the situation is continued and, hence, that adequate surveillance is in place to make sure that the Norwegian territory is free from Aujeszky’s disease.
Norveška je Nadzornemu organu Efte predložila dokazno dokumentacijo zlasti o nadaljnjem spremljanju stanja in izvajanju ustreznega nadzora za zagotovitev, da na ozemlju Norveške ni bolezni Aujeszkega.